数字农科院2.0

Pharmacokinetics of Mequindox and Its Metabolites in Swine

文献类型： 外文期刊

作者： Liu Yi-ming;Liu Ying-chun;Ding Huan-zhong;Fang Bing-hu;Yang Fan;Shan Qi;Zeng Zhen-ling;Liu Ying-chun

作者机构：

关键词： mequindox;metabolites;pharmacokinetics;HPLC;swine

期刊名称： AGRICULTURAL SCIENCES IN CHINA

ISSN： 1671-2927

年卷期： 2011 年 10 卷 12 期

页码：

收录情况： SCI

摘要： The present study was carried out to investigate the pharmacokinetics of mequindox (MEQ), a new synthetic quinoxaline 1,4-dioxide derivative and its two main metabolites M1 [2-isoethanol mequinoox], M2 [2-isoethanol 1-desoxymequindox] in healthy swine. MEQ (10 mg kg(-1) body weight) was administered to nine healthy cross-bread swine via oral, intramuscular, and intravenous routes in a randomized 3x3 crossover design with a 1-wk washout period. A sensitive high-performance liquid chromatography (HPLC) method was used for the determination of plasma concentrations of MEQ and its metabolites M1 and M2. Plasma concentration versus time profiles of MEQ and its metabolites, M1 and M2, were analyzed by non-compartmental analysis using WinNonlin 5.2 software. The mean maximum concentrations (C(max)) of M1 and M2 after intravenous administration of MEQ were (5.27 +/- 1.59) mu g mL(-1) at 1.78 h and (1.01 +/- 0.29) mu g mL(-1) at 0.92 h, respectively. The mean maximum concentrations (C(max)) of MEQ, M1, and M2 were found to be (6.96 +/- 3.23), (6.61 +/- 1.56), and (0.78 +/- 0.25) mu g mL(-1), respectively at 0.15, 1.61, and 1.30 h after intramuscular administration of MEQ, respectively and (0.75 +/- 0.45), (6.90 +/- 1.52), and (0.62 +/- 0.21) mu g mL(-1), respectively at 0.40, 1.57, and 2.00 h, respectively after oral administration of MEQ. The apparent elimination half-lives (t(1/2)) of MEQ, M1 and M2 were (0.84 +/- 0.35), (7.57 +/- 3.93), and (9.56 +/- 6.00) h, respectively after intravenous administration of MEQ; (0.50 +/- 0.25), (6.30 +/- 3.00), and (5.94 +/- 2.54) h, respectively after intramuscular administration of MEQ; and (1.64 +/- 1.17), (5.59 +/- 1.93), and (16.25 +/- 10.27) h, respectively after oral administration of MEQ. The mean areas under the plasma concentration-time curve (AUC(0-infinity)) of MEQ, M1, and M2 were (4.88 +/- 1.54), (36.93 +/- 17.50), and (5.16 +/- 1.94) mu g h mL(-1), respectively after intravenous administration of MEQ; (4.18 +/- 0.76), (48.25 +/- 20.82), and (4.88 +/- 2.21) mu g h mL(-1), respectively after intramuscular administration of MEQ; and (1.01 +/- 0.40), (48.83 +/- 20.71), and (5.54 +/- 2.23) mu g h mL(-1), respectively after oral administration of MEQ. MEQ was rapidly absorbed and metabolized in swine after oral, intramuscular, and intravenous administration. Further studies are required to investigate the double-peak phenomenon observed in the plasma concentration-time profile after oral administration and the pharmacokinetics of other metabolites of MEQ.

分类号：

  • 相关文献

[1]Pharmacokinetics of mequindox and its metabolites in rats after intravenous and oral administration. Li, Guanghui,Yang, Fan,He, Limin,Ding, Huanzhong,Sun, Na,Liu, Yingchun,Liu, Yiming,Shan, Qi,Li, Yafei,Zeng, Zhenling,Li, Guanghui,Yang, Fan,Liu, Yingchun,Liu, Yiming. 2012

[2]Metabolism of mequindox and its metabolites identification in chickens using LC-LTQ-Orbitrap mass spectrometry. Shan, Qi,Liu, Yiming,He, Limin,Ding, Huanzhong,Huang, Xianhui,Yang, Fan,Li, Yafei,Zeng, Zhenling,Liu, Yiming.

[3]Analysis of 10 Metabolites of Polymethoxyflavones with High Sensitivity by Electrochemical Detection in High-Performance Liquid Chromatography. Zheng, Jinkai,Bi, Jinfeng,Johnson, David,Sun, Yue,Song, Mingyue,Qiu, Peiju,Dong, Ping,Decker, Eric,Xiao, Hang.

[4]运用反向遗传学培养产生高成长性的猪流感疫苗(英文). TaoYangMingLiuChunguoLiuYunZhangDafeiLiuHaoChenBiotechnologyAnimalInfluenzaLaboratoryoftheMinistryAgricultureandNationalKeyLaboratoryofVeterinary,HarbinVeterinaryResearchInstituteofCAAS,Harbin150001,China. 2007

[5]Validated hydrophilic interaction LC-MS/MS method for simultaneous quantification of dacarbazine and 5-amino-4-imidazole-carboxamide in human plasma. Yang, Yuhui,Zhang, Weihua,Liu, Yanhong.

[6]Cytotoxicity of mequindox and its metabolites in HepG2 cells in vitro and murine hepatocytes in vivo. Liu, Yingchun,Jiang, Wei,Chen, Yongjun,Zeng, Peng,Xue, Feiqun,Wang, Quan,Liu, Yanyan.

[7]中国H3亚型流感病毒生态学与分子进化的研究(简报). 崔尚金,李建伟,孟庆文,金红,唐秀英,于康震,刘尚高. 2001

[8]不同亚型流感病毒NP基因的原核表达研究. 刘大飞,杨涛,刘明,刘春国,何利昆,刘大程,桑学波. 2007

[9]猪瘟的流行病学及免疫对策. 梁琳,罗亚坤,周灵,崔尚金. 2015

[10]猪流感病毒H3N2亚型PB1-F2蛋白的原核表达. 陈培君,王晓杜,罗金燕,刘超,沈阳,邱亚峰,李向东,王豪举,马志永. 2009

[11]中国猪流感病毒分离株HA1基因序列同源性及遗传演化研究. 李海燕,于康震,杨焕良,辛晓光,崔尚金,赵朴,毕英佐. 2002

[12]非典型猪瘟及其防制. 邱昌庆. 2002

[13]2014年我国2.1d亚型猪瘟病毒JSZL全基因组测序及分析. 张洪亮,冯丽苹,冷超粮,陈家锃,刘春晓,白云,王倩,安同庆,彭金美,蔡雪辉,田志军,童光志. 2015

[14]古典H1N1亚型猪流感病毒反向遗传操作平台的建立. 汪秀会,宫晓倩,刘晓敏,阮宝阳,李泽君,周艳君,童光志,于海. 2014

[15]LC-Tandem-MS development and validation for the determination of tegaserod in beagle dog plasma and its application to a pharmacokinetic study. Zhang, Shuang-Qing,Zhang, Shuang-Qing,Chen, Guo-Hua. 2008

[16]Simultaneous Determination of Six Compounds in Wen-Pi-Tang-Hab-Wu-Ling-San Using an HPLC-DAD Method and Application in a Pharmacokinetic Study. Chen, Jianbo,Chen, Jianbo,Kim, Youngho,Kang, Jongseong,Chen, Jianbo,Byun, Youngjoo,Park, Yongki. 2015

[17]A bioisosteres' application as internal standard for simultaneous determination of three triazine anticoccidial chemicals by UPLC. Ma, Danpeng,Xue, Feiqun,Zhang, Lifang,Fei, Chenzhong,Ma, Danpeng,Zhang, Yue.

[18](-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice. Liao, Bingwu,Ying, Hao,Fan, Zhaoyang,Zhang, Weihua,Ravichandran, Nagaiya,Du, Qizhen,Yu, Chenhuan,Ying, Huazhong,Shi, John,Xu, Yongquan,Yin, Junfeng,Jiang, Yongwen.

[19]Stereoselective Pharmacokinetics of Diniconazole Enantiomers in Rabbits. Cao, Aocheng,Qiu, Jing,Zhou, Zhiqiang,Zhu, Wentao,Dang, Ziheng,Wang, Xinquan.

[20]Plasma pharmacokinetics of melamine and a blend of melamine and cyanuric acid in rainbow trout (Oncorhynchus mykiss). Xue, Min,Qin, Yuchang,Wang, Jia,Wu, Xiufeng,Zheng, Yinhua,Wang, Qiuyan,Xue, Min,Qiu, Jing. 2011

作者其他论文 更多>>